Newborns in Wales and Southwest England struck down with severe Myocarditis

On 16 May, the World Health Organisation (WHO) issued an alarming press release on a cluster of hospitalised neonates (newborns) from Wales and Southwest England, suffering from myocarditis, between June 2022 and April 2023.

A day later, the press release was updated to correct the number of cases and deaths. Ten hospitalised neonates (15 originally) and 1 death (2 deaths originally) were reported in the updated version.

The report stated: ‘On 5 April 2023, the National IHR Focal Point for the United Kingdom informed WHO of an increase in severe myocarditis in neonates and infants associated with enterovirus infection in Wales.’

It went on to make a striking comment, ‘Although enterovirus infections are common in neonates and young infants, the reported increase in myocarditis with severe outcomes in neonates and infants associated with enterovirus infection is unusual.’

Enteroviruses are named by their transmission-route through the intestine ('enteric' meaning intestinal). The fact that the WHO makes a point of stating how unusual the cases are of myocarditis with severe outcomes in neonates and infants, is quite telling.

The troubling WHO press release was picked up by the Daily Mail. According to the article, Dr Christopher Williams, consultant epidemiologist for Public Health Wales, said: 

'In very young babies, enterovirus can, in rare cases, also cause a severe illness in the first few weeks of life. Most babies and children recover completely following enterovirus infection.

'It only affects the heart on very rare occasions. This cluster is unusual due to the number of cases reported in a relatively short time frame.

In December 2022, six young children died from invasive Strep A in the UK, which was later blamed on lockdowns for weakening children’s immunity.

The WHO’s press release concluded, ‘As there is no vaccine for this virus, control measures during outbreaks are focused on classical hygiene measures including frequent handwashing and disinfection of soiled clothing and surfaces. In certain situations, it may be advisable to close child-care facilities and schools to reduce the intensity of transmission.it may be advisable to close child-care facilities and schools to reduce the intensity of transmission.’

School closures and of course, ‘no vaccine for this virus,’ is something that we’re all too painfully familiar with.

Apparently, ‘epidemiological investigations are ongoing’, yet, I highly doubt that any of the clinical investigators will be looking into whether the mothers of these newborns were administered with the experimental COVID-19 mRNA vaccine, whilst pregnant or breastfeeding, and more importantly if it had anything to do with the ‘surge’. Myocarditis is one of the known side effects of the mRNA vaccines. My explosive report first published in Children’s Health Defense, Europe, revealed how the European Medicines Agency (EMA), Pfizer and BioNTech knew about the devastating harms to foetuses and newborns from being exposed to the vaccine trans-placentally and trans-mammary (through the breast milk).

Alarming adverse event cases were mentioned throughout the Periodic Safety Update Reports (PSURs), prepared by Pfizer/BioNTech for the EMA, from early 2021 onwards. Strokes and respiratory adverse events of special interest such as neonatal respiratory failure, newborn persistent pulmonary hypertension and cardiac disorders such foetal tachycardia were listed among the ‘cases involved exposure to the vaccine during the mother’s pregnancy or through breast feeding.’

The screenshots below are taken from PSUR #1 which covered the period of 19 December 2020 to 18 June 2021. It makes for disturbing reading.